202206010103/Guangzhou Science and Technology Plan Projects[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2024	2
2025	1

Page 1

Induction Immunochemotherapy Yields a Higher Conversion Rate and Better Overall Survival than Chemotherapy in Initially Unresectable Esophageal Squamous Cell Carcinoma.

Huang S, Wang S, Gao Z, Li Z, Wu H, Xu W, Tang Y, He Z, Fu J, Qiao G. Huang S, et al. Ann Surg Oncol. 2024 Oct;31(10):6635-6644. doi: 10.1245/s10434-024-15458-8. Epub 2024 May 25. Ann Surg Oncol. 2024. PMID: 38796589

Association Between Treatment-Related Adverse Event Trajectory and Prognosis in Esophageal Cancer Receiving Neoadjuvant Immunochemotherapy.

Li Z, Huang S, Chen R, Gao Z, Wu J, Chen Y, Zhong W, Wang S, Qiao G. Li Z, et al. Ann Surg Oncol. 2024 Dec 27. doi: 10.1245/s10434-024-16811-7. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39730967

ASO Author Reflections: Trajectory of Treatment-Related Adverse Events During Neoadjuvant Immunochemotherapy in Esophageal Cancer: A Further Step Toward Personalized Medicine.

Li Z, Huang S, Chen R, Qiao G. Li Z, et al. Ann Surg Oncol. 2025 Jan 9. doi: 10.1245/s10434-024-16867-5. Online ahead of print. Ann Surg Oncol. 2025. PMID: 39789276 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year